AI doctors, factory robots, and drones on the Great Wall: how China embraced artificial intelligence
While much of the West debates AI cautiously, China has woven it into daily life at speed, from millions of patients chatting with virtual doctors to state surveillance tools that watch city streets.
Key points
- Millions of people in China are already using AI-powered virtual doctors for medical consultations.
- Intelligent robots now work alongside humans on Chinese factory floors.
- Food delivery drones operate at tourist sites including the Great Wall of China.
- The Chinese state has adopted AI surveillance tools as a central part of its monitoring infrastructure.
- Western countries have met AI's spread with noticeably more public scepticism than China.
A patient in Shanghai opens an app, types symptoms, and receives a diagnosis from a digital avatar, a computer-generated doctor that can listen, respond and advise. No waiting room. It's everyday life for millions of Chinese citizens, not a pilot programme.
That's the picture Amy Hawkins, The Guardian's senior China correspondent, painted in a recent interview about how thoroughly AI has settled into Chinese society.
Factories run intelligent robots that adapt to the production line around them. Delivery drones, small autonomous aircraft that carry packages without a human pilot, drop food orders at spots along the Great Wall. AI diagnostic tools, software trained to spot illness from symptoms or scans, handle consultations that elsewhere would need a GP appointment weeks away.
Why does this matter to people outside China?
China is running the world's largest real-world test of AI in everyday life, and what happens there will shape how other governments and companies choose to move.
The speed points to something beyond technology. Chinese regulators have cleared AI health tools faster than counterparts in the United States or Europe, where patient-safety frameworks move slowly and for good reason. A virtual doctor that gives wrong advice carries real consequences. Independent safety audits and long-term outcome data are still largely absent from public reporting on these tools.
Then there's the surveillance question.
The same AI infrastructure powering a helpful medical avatar also powers systems that track citizens' movements and feed data to state security agencies. These aren't separate programmes: they share technology, computing resources and government backing.
Should patients worry about their data?
For patients the trade-off is direct. Faster access to medical advice is genuinely valuable, especially in rural areas where doctors are scarce. But consultation data doesn't stay private in the way a Western patient might expect.
For the rest of the world watching, China's rollout is a preview and a caution in equal measure. The convenience is real. So are the risks that come when a government controls both the AI and the rules around it.
The gap between China's pace of adoption and the West's is widening. Who holds that data, and who they answer to, is the question that will matter most.
